Carrier Proteins: Clinical Trials

1 trial of Carrier Proteins, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Not yet recruiting 1

Follow Carrier Proteins: new trials by email Literature Review of Carrier Proteins trials Research Report on Carrier Proteins

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ZyVac-TCV Bangladesh Study
Purified Vi capsular polysaccharide of Salmonella typhi conjugated to tetanus toxoid as carrier protein (Typhoid Vi Conjugate Vaccine I.P.). Trade name: ZyVac® TCV - Typhoid Vaccination, Typhoid
Phase 3Not yet recruitingInternational Centre for Diarrhoeal Disease Research, Bangladesh40002025-04-012025-02-07

Conditions studied

Typhoid Fever (1)

Sponsors

International Centre for Diarrhoeal Disease Research, Bangladesh (1)

Countries

Bangladesh (1)